STOCK COMMENTS / EPS CHANGESAccenture ( ACN) estimates boosted at Morgan Stanley through 2014. Company remains leveraged to secular growth trends. Overweight rating and $66 price target. Amgen ( AMGN - Get Report) estimates, target increased at UBS. Shares of AMGN now seen reaching $59, according to UBS. Estimates also increased on updated share count, debt, and Enbrel. Neutral rating. BP plc ( BP) estimates lowered at Oppenheimer. Shares of BP lowered through 2012, Oppenheimer said. Adjusted estimate based on futures oil and gas prices. Outperform rating. CIT Group ( CIT) target cut at Citigroup to $44, Citigroup said. Widening in credit markets that undercuts refinancing efforts. Buy rating. Columbia Sportswear ( COLM) numbers cut at Auriga. Shares of COLM now seen reaching $48, according to Auriga USA. Estimates also reduced, given warm weather in recent months. Hold rating. DuPont ( DD) estimates lowered at Credit Suisse through 2013. Company is being hurt by slower macro growth. Neutral rating and $58 price target. Elan ( ELN) estimates raised at Jefferies through 2012, Jefferies said. One of the top picks for 2012. Buy rating.
Twitter and become a fan on Facebook.